Gerber LLC’s Altimmune ALT Stock Holding History

Gerber LLC’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-206,778	Closed	-$800K	–	87
2025 Q2	$800K	Sell	206,778 -75,000	-27%	-$406K	0.56%	28
2025 Q1	$1.41M	Hold	281,778	–	–	1.17%	15
2024 Q4	$2.03M	Hold	281,778	–	–	1.48%	14
2024 Q3	$1.73M	Hold	281,778	–	–	1.27%	15
2024 Q2	$1.87M	Hold	281,778	–	–	1.47%	15
2024 Q1	$2.87M	Buy	281,778 +26,000	+10%	+$264K	2.41%	12
2023 Q4	$2.88M	Buy	+255,778	New	+$1.07M	2.6%	10

Other funds holding ALT

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BWCS

Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BWM

Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

SFWA

Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Gerber LLC's ALT Position: Q3 2025 in Review

Gerber LLC sold out of Altimmune (ALT) in Q3 2025, closing a stake of 206,778 shares — an estimated $800K sold.

Gerber LLC first reported a position in ALT in Q4 2023 and held it in 7 quarters. The position peaked at $2.88M in Q4 2023. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

Gerber LLC reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
Gerber LLC sold 206,778 Altimmune shares in Q3 2025, an estimated $800K.
Gerber LLC first reported a position in Altimmune in Q4 2023 and held it in 7 quarters.
Gerber LLC's Altimmune position peaked at $2.88M in Q4 2023.
158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Gerber LLC's 13F filing for Q3 2025, filed 28 Oct 2025.